Thromb Haemost 1997; 77(02): 403
DOI: 10.1055/s-0038-1655976
Letter to the Editor
Schattauer GmbH Stuttgart

Antithrombin Morioka (Cys 95-Arg): A Novel Missense Mutation Causing Type I Antithrombin Deficiency

Tetsuo Ozawa
1   Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
,
Yasuhiro Takikawa
2   First Department of Internal Medicine, Iwate Medical University, Morioka, Japan
,
Kenji Niiya
1   Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
,
Takao Fujiwara
2   First Department of Internal Medicine, Iwate Medical University, Morioka, Japan
,
Kazuyuki Suzuki
2   First Department of Internal Medicine, Iwate Medical University, Morioka, Japan
,
Shunichi Sato
2   First Department of Internal Medicine, Iwate Medical University, Morioka, Japan
,
Nobuo Sakuragawa
1   Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
› Author Affiliations
Further Information

Publication History

Received 03 July 1996

Accepted after revision 04 October 1996

Publication Date:
10 July 2018 (online)

 
  • References

  • 1 Vidaud D, Emmerich J, Sirieix ME, Alhenc-Gelas M, Aiach M. Molecular basis for antithrombin III type I deficiency:Three novel mutations located in exon IV. Blood 1991; 78: 2305-2309
  • 2 Olds RJ, Lane DA, Chowdhury V, De StefanoV, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene:evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216-4224
  • 3 Sun XJ, Chang JY. Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. J Biol Chem 1989; 264: 11288-11293
  • 4 Emmerich J, Vidaud D, Alhenc-Gelas M, Chadeuf G, Gouault-Heilmann M, Aillaud MF, Aiach M. Three novel mutations of antithrombin inducing high molecular-mass compounds. Arteroscler Thromb 1994; 14: 1958-1965